MARSHALL WACE, LLP - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 151 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$100,109
-65.5%
62,180
-18.8%
0.00%
-100.0%
Q3 2022$290,000
-73.5%
76,606
+0.4%
0.00%
-80.0%
Q1 2021$1,096,000
-91.2%
76,274
-87.9%
0.01%
-92.5%
Q4 2020$12,420,000
+248.9%
632,743
+130.4%
0.07%
+191.3%
Q3 2020$3,560,000
-68.3%
274,670
-64.4%
0.02%
-70.9%
Q2 2020$11,248,000
+1880.3%
771,966
+5295.3%
0.08%
+2533.3%
Q1 2019$568,00014,3080.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,610,00011.42%
Redmile Group, LLC 6,048,123$9,737,4780.37%
Baupost Group 9,773,616$15,7360.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 170,000$273,7000.27%
MAVERICK CAPITAL LTD 6,290,713$10,128,0480.22%
683 Capital Management, LLC 1,000,000$1,610,0000.12%
WASATCH ADVISORS LP 8,283,981$13,337,2090.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$845,2500.08%
STALEY CAPITAL ADVISERS INC 750,000$1,207,5000.06%
XTX Topco Ltd 136,841$220,3140.04%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders